Cadrenal Therapeutics to Present at the NobleCon 19 Conferen

PONTE VEDRA, Fla., Nov. 30, 2023 /PRNewswire/ -- Cadrenal Therapeutics, Inc., (Nasdaq: CVKD), a biopharmaceutical company developing tecarfarin, a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent

Related Keywords

Robert Blum , Quang Pham , Matthew Szot , Boca Raton , Nasdaq , Prnewswire Cadrenal Therapeutics Inc , Lytham Partners , Growth Equity Conference At Florida Atlantic University , Cadrenal Therapeutics Inc , Capital Market Nineteenth , Annual Emerging Growth Equity Conference , Florida Atlantic University , Executive Education Complex , Noble Capital Market Conference , Fast Track , Vitamink Antagonist , Business ,